Investment
Features
FeesSafety
Academy
More
Pluang+

NYSE's parent tests Avalanche for 24/7 tokenized stock trading with instant settlement.

Protocol Fundamentals
18 Sep 2026
Crypto Briefing
View Source
Bullish
NYSE's parent tests Avalanche for 24/7 tokenized stock trading with instant settlement.

The Intercontinental Exchange (ICE), parent company of the New York Stock Exchange (NYSE), has spent a year evaluating Avalanche's blockchain technology for a potential on-chain Alternative Trading System (ATS). This system aims to enable 24/7 trading of tokenized stocks with instant settlement, improving on traditional market hours and settlement times. While Avalanche meets many technical requirements, ICE has not yet made a formal decision. The project could revolutionize stock trading by allowing global investors to trade US equities anytime with near-instant settlement, but regulatory and technical complexities remain.

The story about Ava Labs president detailing NYSE's year-long testing of Avalanche technology is presented here with Pluang's market data for context. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Sep 18, 2026 21:36 WIB: out of 50 major cryptocurrencies, 46 rose and 3 fell. THETA led gains with a 12.84% increase and a typical hold time of 77 days, contrasting with SUSHI which rose 10.52% but saw 83% of orders as sell. BAL also gained 11.14%, holding the longest typical hold time of 85 days among the three.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
2 hours ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
3 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
3 hours ago
HYPE token hits new all-time high after Hyperliquid enables manual USDC/USDT borrowing with HYPE and Bitcoin collateral.

HYPE token hits new all-time high after Hyperliquid enables manual USDC/USDT borrowing with HYPE and Bitcoin collateral.

HYPE token surged 10.5% to $91.20, reaching a new all-time high of $92.56 after Hyperliquid launched manual borrowing of USDC and USDT using HYPE and Bitcoin as collateral. The platform offers a 65% loan-to-value ratio for HYPE, higher than Bitcoin's...

Market News
Bullish
4 hours ago
CleanTech hires Mercator for independent report on fluorspar project in Kentucky, advancing critical mineral exploration.

CleanTech hires Mercator for independent report on fluorspar project in Kentucky, advancing critical mineral exploration.

CleanTech Vanadium Mining Corp. has engaged Mercator Geological Services to prepare an independent technical report on its Campbell-Crotser fluorspar project in Kentucky, following National Instrument 43-101 standards. The report will detail geology,...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App